Tonix Pharmaceuticals Holding (TNXP) Current Leases (2019 - 2026)

Tonix Pharmaceuticals Holding has reported Current Leases for 8 years, with the latest figure at $250000.0 in Q2 2026.

• On a quarterly basis, Current Leases rose 28.21% year-over-year to $250000.0 in Q2 2026; TTM through Jun 2026 was $250000.0, a 28.21% increase from a year earlier, with the FY2025 full-year figure at $125000.0, down 54.38% from the prior year.
• Current Leases was $250000.0 for Q2 2026 at Tonix Pharmaceuticals Holding, up from $162000.0 in the prior quarter.
• The five-year high for Current Leases was $511000.0 in Q2 2022, with the low at $125000.0 in Q4 2025.
• Average Current Leases over 5 years is $313944.4, with a median of $276000.0 recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Current Leases plunged 54.38% in 2025, then grew 28.21% in 2026.
• Over 5 years, Current Leases stood at $432000.0 in 2022, then plunged by 37.5% to $270000.0 in 2023, then grew by 1.48% to $274000.0 in 2024, then slumped by 54.38% to $125000.0 in 2025, then jumped by 100.0% to $250000.0 in 2026.
• The last three Current Leases figures came in at $250000.0 (Q2 2026), $162000.0 (Q1 2026), and $125000.0 (Q4 2025), per Business Quant data.